A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Public ClinicalTrials.gov record NCT06564311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With Relapsing Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis
Study identification
- NCT ID
- NCT06564311
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 93 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 25, 2024
- Primary completion
- Aug 27, 2025
- Completion
- Jan 31, 2026
- Last update posted
- Nov 16, 2025
2024 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Central Neurology | Cullman | Alabama | 35058 | — |
| Center for Neurology and Spine | Phoenix | Arizona | 85032 | — |
| Perseverance Research Center | Scottsdale | Arizona | 85253 | — |
| Regina Berkovich MD PhD, Inc | West Hollywood | California | 90048 | — |
| Aqualine Clinical Research | Naples | Florida | 35105 | — |
| University of South Florida | Tampa | Florida | 33620 | — |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01655 | — |
| Infusion Associates Plymouth | Plymouth | Minnesota | 55446 | — |
| MS Center for Innovations in Care | St Louis | Missouri | 63131 | — |
| Holy Name Medical Center | Teaneck | New Jersey | 07666 | — |
| Boster Center for MS | Columbus | Ohio | 43235 | — |
| North Texas Institute of Neurology and Headache | Plano | Texas | 75024 | — |
| Center for Neurological Disorders | Greenfield | Wisconsin | 53228 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06564311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2025 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06564311 live on ClinicalTrials.gov.